Sort
130,381 grants matching “hiv”
Imaging Virological Synapses During Parenteral HIV Transmission
$847,500Benjamin K Chen · Icahn School Of Medicine At Mount Sinai · DP1 · FY2009 · DA
Therapeutic Dendritic Cell Vaccine for HIV
$847,500Nathaniel R. Landau · New York University School Of Medicine · DP1 · FY2023 · DA
Therapeutic Dendritic Cell Vaccine for HIV
$847,500Nathaniel R. Landau · New York University School Of Medicine · DP1 · FY2018 · DA
Combined cocaine and HIV vaccine
$847,500Timothy J Cardozo · New York University School Of Medicine · DP1 · FY2017 · DA
Optimization of Fc effector activity of anti-HIV antibodies to target HIV reservoir
$847,498Jeffrey Victor Ravetch · Rockefeller University · R01 · FY2021 · AI
Optimization of Fc effector activity of anti-HIV antibodies to target HIV reservoir
$847,498Jeffrey Victor Ravetch · Rockefeller University · R01 · FY2020 · AI
Optimization of Fc effector activity of anti-HIV antibodies to target HIV reservoir
$847,498Jeffrey Victor Ravetch · Rockefeller University · R01 · FY2019 · AI
Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV
$847,498Jessica Robinson-Papp · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · DK
Optimization of Fc effector activity of anti-HIV antibodies to target HIV reservoir
$847,498Jeffrey Victor Ravetch · Rockefeller University · R01 · FY2017 · AI
Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV
$847,498Jessica Robinson-Papp · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · DK
First-in-human study of a potent anti-HBsAg neutralizing antibody
$847,498Marina Caskey · Rockefeller University · U01 · FY2024 · AI
Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV
$847,498Jessica Robinson-Papp · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · DK
Optimization of Fc effector activity of anti-HIV antibodies to target HIV reservoir
$847,498Jeffrey Victor Ravetch · Rockefeller University · R01 · FY2018 · AI
Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV
$847,498Jessica Robinson-Papp · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · DK
JHU-MCAIDS HPTN TRIAL SITE-CHINA
$847,447Johns Hopkins University · U01 · FY2002 · AI
HBV cccDNA and integrated DNA in HIV coinfection and HBV monoinfection
$847,428Daryl T Lau · Beth Israel Deaconess Medical Center · R56 · FY2023 · AI
Protective Immunity
$847,269David I Watkins · University Of Miami School Of Medicine · P01 · FY2014 · AI
Peer-Delivered Behavioral Activation Intervention to Improve Adherence to MAT Among Low-Income, Minority Individuals With OUD
$847,257Jessica F Magidson · Univ Of Maryland, College Park · R33 · FY2023 · DA
Understanding HIV-1 persistence and HIV-1-induced inflammation in tissues
$847,245Ya-Chi Ho · Yale University · R01 · FY2025 · AI
Nonhuman Primate
$847,213Michael K Axthelm · Oregon Health & Science University · P01 · FY2011 · AI
Understanding Unconventional CD8+ T cell Responses in Protection from HIV
$847,205Jonah B. Sacha · Oregon Health & Science University · R01 · FY2018 · AI
Therapeutic use of an enhanced form of CD4-Ig
$847,177Michael R. Farzan · Scripps Florida · R01 · FY2013 · AI
Implementing a Community-Based Response to the Opioid Epidemic in Rural Ohio
$847,166William C Miller · Ohio State University · UH3 · FY2021 · DA
Identification of novel Th17 inducing CTLR agonists for vaccines against mycobacterium tuberculosis
$847,164Jay Evans · University Of Montana · N01 · FY2019 · AI
Role of HIV-1 integrase in virion morphogenesis and its targeting by allosteric integrase inhibitors
$847,141Mamuka Kvaratskhelia · University Of Colorado Denver · R01 · FY2024 · AI